Quest Diagnostics Incorporated (BMV:DGX)
Mexico · Delayed Price · Currency is MXN 3,132.50
-87.50 (-2.72%)
At close: Jul 11, 2025
Sage Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 950 | 871 | 854 | 946 | 1,995 | 1,431 | Upgrade |
Depreciation & Amortization | 543 | 493 | 439 | 437 | 408 | 361 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | -314 | - | Upgrade |
Stock-Based Compensation | 89 | 88 | 77 | 77 | 79 | 97 | Upgrade |
Provision & Write-off of Bad Debts | 4 | 5 | 1 | 3 | 4 | 19 | Upgrade |
Other Operating Activities | 136 | 78 | 46 | 136 | -26 | 75 | Upgrade |
Change in Accounts Receivable | -73 | -71 | -15 | 246 | 81 | -455 | Upgrade |
Change in Accounts Payable | 33 | -67 | -55 | -149 | 35 | 452 | Upgrade |
Change in Income Taxes | 5 | 16 | -2 | -31 | -20 | 22 | Upgrade |
Change in Other Net Operating Assets | -9 | -79 | -73 | 53 | -9 | 3 | Upgrade |
Operating Cash Flow | 1,678 | 1,334 | 1,272 | 1,718 | 2,233 | 2,005 | Upgrade |
Operating Cash Flow Growth | 34.46% | 4.87% | -25.96% | -23.06% | 11.37% | 61.30% | Upgrade |
Capital Expenditures | -454 | -425 | -408 | -404 | -403 | -418 | Upgrade |
Cash Acquisitions | -1,933 | -2,164 | -611 | -144 | -331 | -330 | Upgrade |
Investment in Securities | - | - | - | - | 755 | -24 | Upgrade |
Other Investing Activities | 13 | 41 | -42 | 5 | - | - | Upgrade |
Investing Cash Flow | -2,374 | -2,548 | -1,061 | -543 | 21 | -772 | Upgrade |
Long-Term Debt Issued | - | 1,846 | 2,592 | - | - | 749 | Upgrade |
Long-Term Debt Repaid | - | -303 | -1,844 | -2 | -2 | -1,554 | Upgrade |
Net Debt Issued (Repaid) | 1,243 | 1,543 | 748 | -2 | -2 | -805 | Upgrade |
Issuance of Common Stock | 87 | 73 | 72 | 123 | 129 | 189 | Upgrade |
Repurchase of Common Stock | -194 | -175 | -303 | -1,436 | -2,221 | -340 | Upgrade |
Common Dividends Paid | -342 | -331 | -314 | -305 | -309 | -297 | Upgrade |
Other Financing Activities | -48 | -26 | -43 | -112 | -137 | -14 | Upgrade |
Financing Cash Flow | 746 | 1,084 | 160 | -1,732 | -2,540 | -1,267 | Upgrade |
Foreign Exchange Rate Adjustments | -2 | -7 | - | - | - | - | Upgrade |
Net Cash Flow | 48 | -137 | 371 | -557 | -286 | -34 | Upgrade |
Free Cash Flow | 1,224 | 909 | 864 | 1,314 | 1,830 | 1,587 | Upgrade |
Free Cash Flow Growth | 39.89% | 5.21% | -34.25% | -28.20% | 15.31% | 88.26% | Upgrade |
Free Cash Flow Margin | 11.63% | 9.21% | 9.34% | 13.30% | 16.96% | 16.82% | Upgrade |
Free Cash Flow Per Share | 10.78 | 8.04 | 7.65 | 11.14 | 14.30 | 11.67 | Upgrade |
Cash Interest Paid | 302 | 262 | 134 | 156 | 159 | 201 | Upgrade |
Cash Income Tax Paid | 248 | 256 | 317 | 283 | 709 | 360 | Upgrade |
Levered Free Cash Flow | 924.5 | 741 | 669.75 | 1,015 | 1,564 | 1,104 | Upgrade |
Unlevered Free Cash Flow | 1,094 | 882.25 | 771.63 | 1,108 | 1,659 | 1,208 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.